Modern Africa Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Modern Africa Today.

Press releases published on April 21, 2026

Apr. 21, 2026

TradeView Unveils Perps DEX Platform as Ongoing Presale Hits New Milestone

Indeterminate GlobeNewswire

Apr. 21, 2026

Revolution Medicines to Present Pivotal Phase 3 RASolute 302 Clinical Trial Results for Daraxonrasib in Previously Treated Metastatic Pancreatic Cancer During a Plenary Session at the 2026 ASCO Annual Meeting

Indeterminate GlobeNewswire

Apr. 21, 2026

TradeView Releases New Guide on Platform Utility and Market Position

Indeterminate GlobeNewswire

Apr. 21, 2026

ITM to Announce Quality of Life Data from the Phase 3 COMPETE Trial in Patients with Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) at ASCO 2026

Indeterminate GlobeNewswire

Apr. 21, 2026

Aprea Therapeutics to Provide Clinical Update on ACESOT-1051 Phase 1 Trial Evaluating WEE1 Inhibitor, APR-1051, at ASCO 2026 Annual Meeting

Indeterminate GlobeNewswire

Apr. 21, 2026

Dewpoint Therapeutics Reports Preclinical Data on Oral MYC Condensate Modulator at AACR 2026

Indeterminate GlobeNewswire

Apr. 21, 2026

Leads Biolabs' PD-L1/4-1BB Bispecific Antibody Opamtistomig (LBL-024) Enters Phase Ⅱ Trial with First Patient Dosing in Gastric Cancer, Pioneering Enhanced Immunotherapy Combination Strategies

Indeterminate GlobeNewswire

Apr. 21, 2026

Outlook Therapeutics Completes Federal Dispute Resolution (FDR) Meeting with FDA for ONS-5010/LYTENAVA™ (bevacizumab-vikg)

Indeterminate GlobeNewswire

Apr. 21, 2026

Fortrea Announces Date for First Quarter 2026 Financial Results and Conference Call

Indeterminate GlobeNewswire

Apr. 21, 2026

Neuronetics to Report First Quarter 2026 Financial and Operating Results and Host Conference Call

Indeterminate GlobeNewswire

Apr. 21, 2026

Oncotelic Therapeutics Inc. (OTCQB: OTLC) Leveraging Expertise amid Evaluation Evolution

Indeterminate GlobeNewswire

Apr. 21, 2026

Allogene Therapeutics Expands Pivotal Phase 2 ALPHA3 Trial to South Korea and Australia

Indeterminate GlobeNewswire

Apr. 21, 2026

Polaryx Therapeutics Receives U.S. FDA Fast Track Designations for All Four Indications to be Evaluated in the SOTERIA Basket Trial

Indeterminate GlobeNewswire

Apr. 21, 2026

Enlivex Announces Second Regulatory Approval for Phase 2b Trial of Allocetra in Age-Related Primary Moderate-to-Severe Knee Osteoarthritis

Indeterminate GlobeNewswire

Apr. 21, 2026

Critical Metals Corp. (Nasdaq: CRML) Announces Private Placement of Ordinary Shares for Proceeds of $60 Million

Indeterminate GlobeNewswire

Apr. 21, 2026

Trident Resources Announces Closing of Purchase of Additional 4,711 Hectares at the Contact Lake Gold and Greywacke Gold Projects

Indeterminate GlobeNewswire

Apr. 21, 2026

Cogent Biosciences Announces Oral Presentation of Positive Phase 3 PEAK Trial in Gastrointestinal Stromal Tumors (GIST) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting

Indeterminate GlobeNewswire

Apr. 21, 2026

Corvus Pharmaceuticals to Host Investor and Analyst Meeting on May 14, 2026 to Highlight Soquelitinib Data Being Presented at the Society for Investigative Dermatology (SID) Annual Meeting

Indeterminate GlobeNewswire

Apr. 21, 2026

Annual General and Special Meeting of Shareholders to be held May 7, 2026

Indeterminate GlobeNewswire

Apr. 21, 2026

Medicenna Presents Positive Data Demonstrating Superior Safety and Efficacy Potential of its First-in-Class anti-PD-1 x IL-2 Bifunctional Superkine MDNA113 at AACR 2026

Indeterminate GlobeNewswire